Skeletal muscle cell growth and differentiation media

Provitro’s skeletal muscle cell growth media were developed to provide skeletal muscle cells with optimal growth conditions in a low serum environment. After confluence, following addition of differentiation medium, the proliferating satellite cells start to form syncytia. Provitro’s skeletal muscle cell basal media are supplemented with FCS 5%, recombinant human EGF and bFGF, fetuin, dexamethasone and insulin for the growth medium and with insulin for the differentiation medium, respectively.

Based on the expertise of provitro and some of our customers, our skeletal muscle cell growth media are recommended for skeletal muscle cells of the species listed below:

Skeletal muscle growth medium, low serum

  • Human skeletal muscle cells.
Skeletal muscle cell growth medium, basal
OFFER NO PRODUCT SPECIFICS DETAILS
200 0602 Skeletal muscle cell growth medium, basal Basal
Skeletal muscle cell growth medium
OFFER NO PRODUCT SPECIFICS DETAILS
201 0602 Skeletal muscle cell growth medium FCS
211 0602 Skeletal muscle cell growth medium FCS kit
212 0602 Skeletal muscle cell growth medium HuS kit
Supplementation with
SUBSTANCE FINAL CONC./ML GROWTH MEDIUM
FCS or HuS 000.05 ml
Fetuin 050.00 μg
human rec. EGF 010.00 ng
human rec. bFGF 001.00 ng
Insulin 010.00 μg
Dexamethasone 400.00 ng
Gentamicin 050.00 μg
Amphothericin B 050.00 ng
Skeletal muscle cell differentiation medium
OFFER NO PRODUCT SPECIFICS DETAILS
203 0603 Skeletal muscle cell differentiation medium Serum-free
213 0603 Skeletal muscle cell differentiation medium Serum-free kit
Supplementation with
SUBSTANCE FINAL CONC./ML GROWTH MEDIUM
Insulin 10.0 μg
Gentamicin 50.0 μg
Amphothericin B 50.0 ng
nach oben